T cell activation predicts carotid artery stiffness among HIV-infected women

Atherosclerosis

Volumn 217, Issue 1, 2011, Pages 207-213

  Kaplan, Robert C ^a   Sinclair, Elizabeth ^b   Landay, Alan L ^c   Lurain, Nell ^c   Sharrett, A Richey ^d   Gange, Stephen J ^d   Xue, Xiaonan ^a   Parrinello, Christina M ^a   Hunt, Peter ^b   Deeks, Steven G ^b   Hodis, Howard N ^e  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cardiovascular disease; HIV; Inflammation

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BIOLOGICAL MARKER; CD28 ANTIGEN; CD38 ANTIGEN; CD57 ANTIGEN; HLA DR ANTIGEN;

ADULT; ARTERIAL STIFFNESS; ARTERY COMPLIANCE; ARTERY DIAMETER; ARTICLE; B SCAN; CARDIOVASCULAR RISK; CAROTID ARTERY; CAROTID ARTERY STIFFNESS; CD4 CD28 CD57 T LYMPHOCYTE; CD4 CD38 HLA DR T LYMPHOCYTE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8 CD28 CD57 T LYMPHOCYTE; CD8 CD38 HLA DR T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOLOGY; IMMUNOSENESCENCE; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; SENESCENCE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; VIRUS LOAD; YOUNG MODULUS;

ADULT; ANTIGENS, CD28; ANTIGENS, CD38; ANTIGENS, CD57; CAROTID ARTERIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL AGING; FEMALE; HIV INFECTIONS; HLA-DR ANTIGENS; HUMANS; INFLAMMATION; LYMPHOCYTE ACTIVATION; MIDDLE AGED; MODELS, STATISTICAL; PROSPECTIVE STUDIES; RISK FACTORS; T-LYMPHOCYTES; VASCULAR STIFFNESS;

EID: 79960232165     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.03.011     Document Type: Article

References (31)

1. Blacher J., Pannier B., Guerin A.P., et al. Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension 1998, 32:570-574.
2. Seaberg E.C., Benning L., Sharrett A.R., et al. Association between human immunodeficiency virus infection and stiffness of the common carotid artery. Stroke 2010, 41:2163-2170.
3. Ho J.E., Deeks S.G., Hecht F.M., et al. Initiation of antiretroviral therapy at higher nadir CD4+ T-cell counts is associated with reduced arterial stiffness in HIV-infected individuals. AIDS 2010, 24:1897-1905.
4. Lekakis J., Ikonomidis I., Palios J., et al. Association of highly active antiretroviral therapy with increased arterial stiffness in patients infected with human immunodeficiency virus. Am J Hypertension 2009, 22:828-834.
5. Schillaci G., DeSocio G.V., Pucci G., et al. Aortic stiffness in untreated adult patients with human immunodeficiency virus infection. Hypertension 2008, 52:308-313.
6. Bonnet D., Aggoun Y., Szezepanski I., Bellal N., Blanche S. Arterial stiffness and endothelial dysfunction in HIV-infected children. AIDS 2004, 18:1037-1041.
7. Ooyanagi R., Fuse S., Tomita H., et al. Pulse wave velocity and ankle brachial index in patients with Kawasaki disease. Pediatr Int 2004, 46:398-402.
8. Tuttolomondo A., DiRaimondo D., Pecoraro R., et al. Immune-inflammatory markers and arterial stiffness indexes in subjects with acute ischemic stroke. Atherosclerosis 2010, 213:311-318.
9. Tseke P., Grapsa E., Stamatelopoulos K., et al. Atherosclerotic risk factors and carotid stiffness in elderly asymptomatic HD patients. Int Urol Nephrol 2006, 38:801-809.
10. Kasai T., Inoue K., Kumagai T. Plasma pentraxin3 and arterial stiffness in men with obstructive sleep apnea. Am J Hypertens 2010, [Epub ahead of print].
11. Yasmin, McEniery C.M., Wallace S., et al. C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arterioscler Thromb Vasc Biol 2004, 24:969-974.
12. Nagano M., Nakamura M., Sato K., et al. Association between serum C-reactive protein levels and pulse wave velocity: a population-based cross-sectional study in a general population. Atherosclerosis 2005, 180:189-195.
13. Hansson G.K., Holm J., Jonasson L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol 1989, 135:169-175.
14. Andersson J., Libby P., Hansson G.K. Adaptive immunity and atherosclerosis. Clin Immunol 2010, 134:33-46.
15. Lehoux S., Lemarie C.A., Esposito B., Lijnen H.R., Tedgui A. Pressure-induced matrix metalloproteinase-9 contributes to early hypertensive remodeling. Circulation 2004, 109:1041-1047.
16. Medley T.L., Kingwell B.A., Gatzka C.D., Pillay P., Cole T.J. Matrix metalloproteinase-3 genotype contributes to age-related aortic stiffening through modulation of gene and protein expression. Circ Res 2003, 92:1254-1261.
17. Kaplan R.C., Sinclair E., Landay A.L., et al. T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women. J Infect Dis 2011, 203:452-463.
18. Selzer R.H., Hodis H.N., Kwong-Fu H., et al. Evaluation of computerized edge tracking for quantifying intima-media thickness of the common carotid artery from B-mode ultrasound images. Atherosclerosis 1994, 111:1-11.
19. Selzer R.H., Mack W.J., Lee P.L., Kwong-Fu H., Hodis H.N. Improved common carotid elasticity and intima-media thickness measurements from computer analysis of sequential ultrasound frames. Atherosclerosis 2001, 154:185-193.
20. Hodis H.N., Mack W.J., Lobo R.A., et al. Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2001, 135:939-953.
21. Lage S.G., Kopel L., Monachini M.C., et al. Carotid arterial compliance in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol 1994, 74:691-695.
22. Palella F.J., Gange S.J., Benning L., et al. Inflammatory biomarkers and abacavir use in the Women's Interagency HIV Study and the Multicenter AIDS Cohort Study. AIDS 2010, 24:1657-1665.
23. Neuhaus J., Jacobs D.R., Baker J.V., et al. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis 2010, 201:1788-1795.
24. Hunt P.W., Brenchley J., Sinclair E., et al. Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis 2008, 197:126-133.
25. Kaplan R.C., Kingsley L.A., Gange S.J., et al. Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men. AIDS 2008, 22:1615-1624.
26. Hsue P.Y., Lo J.C., Franklin A., et al. Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation 2004, 109:1603-1608.
27. Chetty R. Vasculitides associated with HIV infection. J Clin Pathol 2001, 54:275-278.
28. Regina G., Impedovo G., Angiletta D., et al. Surgical experience with carotid stenosis in young HIV-1 positive patients under antiretroviral therapy: an emerging problem?. Eur J Vasc Endovasc Surg 2005, 29:167-170.
29. Torriani F.J., Komarow L., Parker R.A., et al. Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: the ACTG (AIDS Clinical Trials Group) Study 5152s. J Am Coll Cardiol 2008, 52:569-576.
30. Giorgi J.V, Hultin L.E., McKeating J.A., et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 1999, 179:859-870.
31. Deeks S.G., Kitchen C.M., Liu L., et al. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 2004, 104:942-947.